Unique AED pads give hearts a second chance

April 26, 2011 in Cardiology

Unique AED pads give hearts a second chance

Enlarge

An invention by Rice University bioengineering students in collaboration with the Texas Heart Institute (THI) is geared toward giving immediate second chances to arrhythmia victims headed toward cardiac arrest.

For their capstone design project, a team of Rice seniors created a unique pad system for automated external defibrillators (AEDs), common devices that can shock a victim's heart back into a proper rhythm in an emergency.

Often, the first shock doesn't reset a heart and the procedure must be repeated, but the sticky pads on the chest must first be repositioned. The pads need to be in the right location to send current through the heart, and someone with no experience who tries to provide aid might miss the first time.

The Second-Chance AED Pads let rescuers try again without losing valuable time to remove the pads from the victim's chest. The pads incorporate three electrodes, two in a single pad with an A/B switch attached, and a third in its own pad.

If one shock doesn't restart the patient's heart, flipping the switch will change the jolt's path, just a little bit, for the second attempt.

This video is not supported by your browser at this time.

The pads were developed by students on the DefibTaskForce -- Lisa Jiang, Joanna Nathan, Justin Lin, Carl Nelson and Brad Otto -- in tandem with Mehdi Razavi, director of electrophysiology clinical research at THI, and their adviser, Renata Ramos, a Rice lecturer in bioengineering.

The potential for their project was clear from the beginning. "We did some calculations that suggested we could save at least 13,000 lives per year," Otto said. "Cardiac defibrillation is very time-sensitive. Thirty seconds can be the difference between life and death in a lot of situations. The time it takes to flip the switch is negligible compared with the time it takes to remove the pads, shave and prep a new area on the body, reapply the pads and administer another shock. And a layman might not even know to try a second position."

Rather than try to build a new type of AED, the team decided early on that it was enough to simply design new pads that would fit devices that are already in use. Manufacturers generally require AED pads be replaced every two years, which provides a ready market for the students' invention. "But well over 100,000 AED units are produced every year, so even if our pads are only paired with new AEDs, we have a significant market," Lin said.

Getting the instructions right turned out to be just as important as the device itself and required a lot of illustrative trial and error. In tests for the final version at Rice's Oshman Engineering Design Kitchen, the team recruited students with no experience using an AED to shock a medical mannequin back to life. "We had 100 percent of the testers place the pads correctly, showing it was very intuitive to use," Jiang said.

All five team members, along with Razavi and Ramos, are listed on the provisional patent. They hope an AED manufacturer will pick up the rights to the Second-Chance pads for clinical trials and ultimately FDA approval.

Provided by Rice University search and more info website

not rated yet  

Rank not rated yet
Related Stories
Relevant PhysicsForums posts

More news stories

Costs to treat stroke in America may double by 2030

Costs to treat stroke are projected to more than double and the number of people having strokes may increase 20 percent by 2030, according to the American Heart Association/American Stroke Association.

Cardiology created 10 hours ago | popularity not rated yet | comments 0

New blood-thinner measures may cut medication errors

Blood thinners are the preferred treatment option to prevent heart attacks, blood clots and stroke, but they are not without risk, and not just because of their side effects. These high-risk drugs, known as anticoagulants, ...

Cardiology created 13 hours ago | popularity not rated yet | comments 0

Registry questions superiority of bivalirudin over heparin

Results from a large observational study reported at EuroPCR 2013 today question whether bivalirudin is superior to heparin in the absence of GPIIb/IIIa blockade, showing similar 30-day mortality in patients with non-ST segment ...

Cardiology created 13 hours ago | popularity not rated yet | comments 0

Study shows low rate of late lumen loss with bioresorbable DESolve device

The DESolve bioresorbable coronary scaffold system achieves good efficacy and safety with low rates of late lumen loss and major coronary adverse events at six months, show first results from the pivotal DESolve Nx trial ...

Cardiology created 13 hours ago | popularity not rated yet | comments 0

Biodegradable stent proves non-inferior to drug-eluting stent

The Orsiro stent, which is a novel stent platform eluting sirolimus from a biodegradable polymer, demonstrated non-inferiority to the Xience Prime everolimus-eluting stent for the primary angiographic endpoint of in-stent ...

Cardiology created May 21, 2013 | popularity 5 / 5 (1) | comments 0


Slowing the aging process—only with antibiotics

Swiss scientists reveal the mechanism responsible for aging hidden deep within mitochondria—and dramatically slow it down in worms by administering antibiotics to the young.

Researchers complete largest genetic sequencing study of human disease

Researchers from Queen Mary, University of London have led the largest sequencing study of human disease to date, investigating the genetic basis of six autoimmune diseases.

Brain can be trained in compassion, study shows

Until now, little was scientifically known about the human potential to cultivate compassion—the emotional state of caring for people who are suffering in a way that motivates altruistic behavior.

Having both migraines, depression may mean smaller brain

(HealthDay)—Migraines and depression can each cause a great deal of suffering, but new research indicates the combination of the two may be linked to something else entirely—a smaller brain.

Novel approach for influenza vaccination shows promise in early animal testing

A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and ferrets. The vaccine ...

Enzyme-activating antibodies revealed as marker for most severe form of rheumatoid arthritis

In a series of lab experiments designed to unravel the workings of a key enzyme widely considered a possible trigger of rheumatoid arthritis, researchers at Johns Hopkins have found that in the most severe ...